Affinity purification of tissue plasminogen activator using transition-state analogues

Area of Science:

• Biochemistry
• Protein Purification
• Biotechnology

Background:

• Tissue plasminogen activator (tPA) is crucial for thrombolysis.
• Efficient purification methods for tPA are essential for therapeutic applications.
• Existing purification strategies can be complex or costly.

Purpose of the Study:

• To develop a simple and effective affinity ligand for purifying tissue plasminogen activator (tPA).
• To identify specific peptide sequences that strongly bind to tPA.

Main Methods:

• Solid-phase synthesis of diverse tripeptide ligands on agarose gels.
• Immobilization of ligands for testing binding affinity with tPA and urokinase.
• Characterization of ligand-tPA interactions, focusing on hemiacetal linkage formation.

Main Results:

• Identified tripeptide ligands with hydrophobic residues, particularly aromatics, flanking argininal showed strong tPA binding.
• A specific ligand, D-Phe-D-Phe-Argal (aldehyde derivative of arginine), demonstrated high efficacy.
• This ligand successfully purified tPA from cell culture media at both milligram and multi-gram scales.

Conclusions:

• Solid-phase synthesis is an effective approach for developing affinity ligands.
• Tripeptide ligands with specific hydrophobic flanking residues can achieve high-affinity binding to tPA.
• The D-Phe-D-Phe-Argal ligand offers a robust and scalable solution for tPA purification.